Alternate Cancer Remedies
(Frank Friedman, Ph.D.) extracted a factor from the larvae of fruit flies which induced tumors in noncancerous insects. He then did research work at Cal Tech, New York University, and St. Vincent’s Hospital, where he was a senior investigator in the Hodgkin’s Disease Research Laboratory.
In the late 1950s, he was back in New York with Friedman again, and they worked with oth- ers at St. Vincent’s in extracting a tumor-inhibit- ing factor from fruit flies. Oddly enough, the pur- pose of the research was not to find an anti-can- cer agent, but to develop a method of speeding cancer experiments and thus save money.
Then they extended these findings to mice. Us- ing similar techniques, they extracted a factor from mouse blood which caused long-term re- mission of cancer in mice. Burton reported on it in June 1959.
The research team was utterly astonished! Within hours, the animals’ cancers would begin to disappear! According to Rottino’s later (1978) re- port, the research was new, original, and dramatic.
In each case, the cancer would eventually re- turn—but the fact that, for a time, it would dimin- ish seemed astounding. They then used some of that factor from mouse blood and applied it, in vitro, to human cancer—and it shrunk down also.
with large, bulging tumors and injected them with what he called a “de-blocking” agent. An hour later, the skeptical audience gathered around—and saw the tumors nearly gone. In a couple more hours, they were completely gone.
Reporters suddenly rushed from the room and manned the phone banks. Banner headlines in Los Angeles read “15-Minute Cancer Cure for Mice: Humans Next?” (Burton later claimed that the American Cancer Society received an additional $4 million from the public for cancer research, following that announcement.)
The demonstration was repeated the next year at the New York Academy of Medicine meeting. But at both meetings, many scientists denounced it as a fraud of some kind.
In later years, it was said that Burton refused to publish his findings. Yet he did do so from 1956 to 1962; but, in 1963, medical journals refused to accept them, so he stopped trying.
By the early 1970s, Burton and Friedman had developed a theory to explain what took place. Tu- mor antibodies (IgG gamma globulin, plus re- lated IgA and IgM proteins) had interacted with de-blocking [unblocking] factors (such as alpha- 2-macroglobulin) and tumor complement.
Burton gave it the name, Immuno-Augmen- tative Therapy (IAT).
This factor consisted of four proteins which they had isolated in both mouse and human blood. These substances they called de-block- ing protein (DP), tumor antibody 1 (TA1), tu- mor antibody 2 (TA2), and tumor complement (TC). Burton claimed that, when used in the right combination, these four substances could restore the normal immune function in cancer patients.
Almost immediately, the Sloan-Kettering Insti- tute sent men to see them. When the researchers at St. Vincent’s turned down their requests to sign contracts, all public and private research grant money to the hospital was suddenly terminated.
The St. Vincent’s team switched from leuke- mic mice to animals with spontaneous breast can- cers. Injecting their mouse-derived tumor-inhibit- ing factor into animals with rock-hard breast tu- mors, they watched in amazement as the growths become soft, spongy, and disappeared within a day or two.
One individual who witnessed the cancer re- ductions, Patrick McGrady, controlled the selec- tion list for the ACS Science Writers’ Seminar, and invited Burton and Friedman to Phenix for the March meeting.
In front of prominent scientists and reporters from across the nation, Burton picked up four mice
In 1975, Burton was offered an opportunity to test his method on humans. So he and Friedman left St. Vincent’s and founded the Immunology Re- search Foundation at Great Neck, New York.
For a brief period, it appeared that the Bur- ton-Friedman technique might be accepted. That same year, there was talk of test trials taking place soon. But they never began.
Apparently, Burton had a hot temper, and is- sued strong comments regarding various devel- opments. Finally, disgruntled with the pressure from official agencies, Burton quit in 1977; he moved to the Bahamas and established a research- treatment center on the ground of the Rand Hos- pital, Grand Bahamas.
After setting up practice in the Bahamas, with a physician assistant, Burton claimed to be hav- ing good success. But his patients were all from overseas, and he did no follow-up studies, nor bothered to issue ongoing written reports of any kind. He was able to be a law to himself since the government loved the way he was bringing in so many tourist dollars. He did not have to report to anyone.
But he did later claim that, of the 186 patients earlier treated in Great Neck between 1974 and 1977, 30 (16%) had what he termed “miracle re- missions—they exhibited no sign of cancer.” Some